FDA Adverse Event Injury Summary report: N

K-Y BRAND JELLY

MDR report key: 2421456 · Received January 19, 2012

Report

Report Number
2214133-2012-00014
Event Type
Injury
Date Received
January 19, 2012
Report Date
January 3, 2012
Manufacturer
SKILLMAN CONTRACT
Product Code
KMJ
PMA / PMN Number
K810310
Removal / Correction Number
NI
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
CA
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

THIS IS A FOREIGN FOLLOW UP REPORT THAT IS BEING SUBMITTED AS A SERIOUS INJURY FOR A PRODUCT THAT IS SAME/SIMILAR TO A US MARKETED PRODUCT. THE DATE OF THIS SUBMISSION IS (B)(4) 2012. THIS CLOSES OUT THIS REPORT UNLESS OTHER ADDITIONAL SIGNIFICANT INFORMATION IS RECEIVED.

Additional Manufacturer Narrative · 1

THIS IS A FOREIGN REPORT THAT IS BEING SUBMITTED AS A SERIOUS INJURY FOR A PRODUCT THAT IS SAME/SIMILAR TO A US MARKETED PRODUCT. THE DATE OF THIS SUBMISSION IS (B)(4) 2012. THIS CLOSES OUT THIS REPORT UNLESS OTHER ADDITIONAL SIGNIFICANT INFORMATION IS RECEIVED.

Description of Event or Problem · 1

THIS SPONTANEOUS REPORT WAS RECEIVED BY A (B)(4) JOHNSON & JOHNSON AFFILIATE ON 03-JANUARY-2012 FROM A CONSUMER REPORTING ON SELF FROM (B)(6). THE MEDICAL HISTORY INCLUDED AN UNSPECIFIED THYROID PROBLEM FOR AN UNSPECIFIED DURATION AND A HYSTERECTOMY IN 2011. THE CONCOMITANT MEDICATIONS WERE NOT REPORTED ON AN UNSPECIFIED DATE IN 2011, THE CONSUMER STARTED USING AN UNSPECIFIED AMOUNT OF K-Y BRAND JELLY TOPICALLY FOR GENERAL LUBRICATION (LOT NUMBER, FREQUENCY AND EXPIRATION DATE UNSPECIFIED) AFTER HAVING UNDERGONE A HYSTERECTOMY. AFTER AN UNSPECIFIED DURATION, THE CONSUMER DEVELOPED A BLADDER INFECTION AND COULD NOT VOID URINE AND WHEN SHE DID IT WAS BLOOD COLORED. THE CONSUMER WAS HOSPITALIZED FOR AN UNSPECIFIED DURATION. THE MEDICAL TREATMENT GIVEN IN THE HOSPITAL WAS NOT SPECIFIED. THE USE OF THE PRODUCT WAS DISCONTINUED ON AN UNSPECIFIED DATE AND THE OUTCOME OF THE EVENTS WERE RECOVERED. THIS REPORT WAS ASSESSED AS SERIOUS (MEDICALLY SIGNIFICANT). THE COMPANY CAUSALITY WAS ASSESSED AS POSSIBLE. ADDITIONAL INFORMATION RECEIVED ON JAN 19 2012: THE QUALITY INVESTIGATION WAS CONCLUDED ON JAN 19 2012 AND NO QUALITY RELATED ISSUES HAVE BEEN IDENTIFIED THAT WOULD WARRANT FURTHER QUALITY INVESTIGATION. THE CUSTOMER DID NOT REPORT A SPECIFIC PRODUCT OR LOT NUMBER FOR INVESTIGATION; THEREFORE, LOT TRENDING COULD NOT BE PERFORMED. A REVIEW OF THE COMPLAINT DATA ASSOCIATED WITH THIS COMPLAINT CATEGORY REVEALED THAT THERE IS ONE OTHER ADVERSE EVENT - OTHER - GENITAL/ANAL/REPRODUCTIVE COMPLAINT REPORTED FOR K-Y JELLY. A REVIEW OF THE COMPLAINT DATA ASSOCIATED WITH THIS COMPLAINT CATEGORY DID NOT IDENTIFY ANY RECENT ADVERSE TREND FOR THIS PRODUCT WITHIN THE PAST 24 MONTHS. THIS REPORT REMAINS SERIOUS (MEDICALLY SIGNIFICANT) AND THE COMPANY CAUSALITY WAS ASSESSED AS POSSIBLE.

Description of Event or Problem · 1

THIS SPONTANEOUS REPORT WAS RECEIVED BY A (B)(6) JOHNSON & JOHNSON AFFILIATE ON (B)(6) 2012 FROM A CONSUMER REPORTING ON SELF FROM (B)(6). THE MEDICAL HISTORY INCLUDED AN UNSPECIFIED THYROID PROBLEM FOR AN UNSPECIFIED DURATION AND A HYSTERECTOMY IN 2011. THE CONCOMITANT MEDICATIONS WERE NOT REPORTED ON AN UNSPECIFIED DATE IN 2011 THE CONSUMER STARTED USING AN UNSPECIFIED AMOUNT OF K-Y BRAND JELLY TOPICALLY FOR GENERAL LUBRICATION (LOT NUMBER, FREQUENCY AND EXPIRATION DATE UNSPECIFIED) AFTER HAVING UNDERGONE A HYSTERECTOMY. AFTER AN UNSPECIFIED DURATION, THE CONSUMER DEVELOPED A BLADDER INFECTION AND COULD NOT VOID URINE AND WHEN SHE DID IT WAS BLOOD COLORED. THE CONSUMER WAS HOSPITALIZED FOR AN UNSPECIFIED DURATION. THE MEDICAL TREATMENT GIVEN IN THE HOSPITAL WAS NOT SPECIFIED. THE USE OF THE PRODUCT WAS DISCONTINUED ON AN UNSPECIFIED DATE AND THE OUTCOME OF THE EVENTS WERE RECOVERED. THIS REPORT WAS ASSESSED AS SERIOUS (MEDICALLY SIGNIFICANT). THE COMPANY CAUSALITY WAS ASSESSED AS POSSIBLE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 K-Y BRAND JELLY LUBRICANT, PATIENT KMJ SKILLMAN CONTRACT NI NI

Patients

Seq Age Sex Outcome Treatment
1 50 YR Hospitalization| R